RNF157 and ovarian carcinoma: Xu and Xu (2020) observed that the higher expression of RNF157-AS1 motivated the proliferation of ovarian cancer cells, while the overexpression of RNF157-AS1 decreased the chemoresistance; thus, ovarian cancer patients with overexpressed RNF157-AS1 have better prognosis.